Everest Medicines Announces Positive Results from In Vitro Study of Taniborbactam (VNRX-5133) in Combination with Cefepime

The study assessed the in vitro activity of the novel -lactamase inhibitor, taniborbactam, when paired with a fourth generation cephalosporin antibiotic, cefepime, against 500 urinary Gram-negative bacilli clinical isolates with major resistance mechanisms collected in Mainland China.